$VRTX
VERTEX PHARMACEUTICALS INC / MA

2015 Q2 Form 10-Q Financial Statement

#000087532015000047 Filed on August 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $166.1M $138.4M
YoY Change 19.98% -55.46%
Cost Of Revenue $15.41M $9.655M
YoY Change 59.6% -60.9%
Gross Profit $150.7M $128.8M
YoY Change 17.01% -54.99%
Gross Profit Margin 90.72% 93.02%
Selling, General & Admin $94.39M $77.45M
YoY Change 21.88% -26.3%
% of Gross Profit 62.65% 60.14%
Research & Development $223.9M $224.5M
YoY Change -0.28% 4.9%
% of Gross Profit 148.58% 174.34%
Depreciation & Amortization $14.00M $14.20M
YoY Change -1.41% 35.24%
% of Gross Profit 9.29% 11.03%
Operating Expenses $318.3M $301.9M
YoY Change 5.4% -5.37%
Operating Profit -$171.2M -$180.5M
YoY Change -5.19% 283.87%
Interest Expense -$21.11M -$15.59M
YoY Change 35.46% 131.68%
% of Operating Profit
Other Income/Expense, Net $1.414M $37.73M
YoY Change -96.25% -111073.53%
Pretax Income -$190.9M -$158.4M
YoY Change 20.5% 194.45%
Income Tax $30.13M $693.0K
% Of Pretax Income
Net Earnings -$188.8M -$159.4M
YoY Change 18.49% 178.81%
Net Earnings / Revenue -113.71% -115.14%
Basic Earnings Per Share -$0.78 -$0.68
Diluted Earnings Per Share -$0.78 -$0.68
COMMON SHARES
Basic Shares Outstanding 240.8M shares 233.8M shares
Diluted Shares Outstanding 240.8M shares 233.8M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.016B $1.219B
YoY Change -16.65% -14.81%
Cash & Equivalents $870.5M $420.6M
Short-Term Investments $146.0M $799.0M
Other Short-Term Assets $141.0M $34.00M
YoY Change 314.71% -66.34%
Inventory $42.11M $11.98M
Prepaid Expenses
Receivables $94.52M $81.84M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.295B $1.347B
YoY Change -3.91% -21.51%
LONG-TERM ASSETS
Property, Plant & Equipment $713.4M $730.0M
YoY Change -2.28% 25.49%
Goodwill $50.38M $30.99M
YoY Change 62.57% -0.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.136M $9.315M
YoY Change -1.92% 117.28%
Total Long-Term Assets $1.079B $770.4M
YoY Change 40.1% -11.21%
TOTAL ASSETS
Total Short-Term Assets $1.295B $1.347B
Total Long-Term Assets $1.079B $770.4M
Total Assets $2.374B $2.118B
YoY Change 12.1% -18.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.70M $55.36M
YoY Change 31.32% 13.99%
Accrued Expenses $206.0M $237.8M
YoY Change -13.36% -8.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $57.00M $20.00M
YoY Change 185.0% 81.82%
Total Short-Term Liabilities $373.8M $363.0M
YoY Change 2.99% -4.89%
LONG-TERM LIABILITIES
Long-Term Debt $768.0M $518.0M
YoY Change 48.26% 33.85%
Other Long-Term Liabilities $41.25M $15.67M
YoY Change 163.32% -2.39%
Total Long-Term Liabilities $41.25M $15.67M
YoY Change 163.32% -2.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $373.8M $363.0M
Total Long-Term Liabilities $41.25M $15.67M
Total Liabilities $1.326B $945.6M
YoY Change 40.22% -8.7%
SHAREHOLDERS EQUITY
Retained Earnings -$5.093B -$4.359B
YoY Change 16.84% 12.13%
Common Stock $5.990B $5.531B
YoY Change 8.29% 6.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $895.0M $1.172B
YoY Change
Total Liabilities & Shareholders Equity $2.374B $2.118B
YoY Change 12.1% -18.05%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$188.8M -$159.4M
YoY Change 18.49% 178.81%
Depreciation, Depletion And Amortization $14.00M $14.20M
YoY Change -1.41% 35.24%
Cash From Operating Activities -$110.3M -$127.9M
YoY Change -13.76% 14111.11%
INVESTING ACTIVITIES
Capital Expenditures -$13.40M -$11.70M
YoY Change 14.53% 550.0%
Acquisitions
YoY Change
Other Investing Activities $291.9M $101.6M
YoY Change 187.3% -3603.45%
Cash From Investing Activities $278.5M $89.90M
YoY Change 209.79% -2012.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.20M 33.40M
YoY Change 8.38% -78.79%
NET CHANGE
Cash From Operating Activities -110.3M -127.9M
Cash From Investing Activities 278.5M 89.90M
Cash From Financing Activities 36.20M 33.40M
Net Change In Cash 204.4M -4.600M
YoY Change -4543.48% -103.03%
FREE CASH FLOW
Cash From Operating Activities -$110.3M -$127.9M
Capital Expenditures -$13.40M -$11.70M
Free Cash Flow -$96.90M -$116.2M
YoY Change -16.61% -13011.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000875320
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
244655527 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.61
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
1645000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
4377000 USD
dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71194000 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
72703000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75964000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94519000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
209676000 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
206030000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-306000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
917000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1707000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5777154000 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5987169000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89473000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
122682000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42444000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
89024000 USD
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
63261000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
120645000 USD
CY2011Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
1100000 sqft
CY2014Q4 us-gaap Assets
Assets
2334679000 USD
CY2015Q2 us-gaap Assets
Assets
2374073000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1546511000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
1294689000 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
761847000 USD
CY2015Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
145907000 USD
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
17806000 USD
CY2015Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
13921000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
8985000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
39293000 USD
CY2015Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
42900000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
569299000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
420558000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
625259000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
870543000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
241764398 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244341701 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241764398 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
244341701 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2385000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
2406000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-159108000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-391556000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-191346000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-390078000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-32144000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-32242000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-159108000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-391556000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-223490000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-422320000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
166000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9655000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
18227000 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
15409000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
24790000 USD
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
318963000 USD
us-gaap Costs And Expenses
CostsAndExpenses
653456000 USD
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
337240000 USD
us-gaap Costs And Expenses
CostsAndExpenses
647734000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17468000 USD
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
14930000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
27808000 USD
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
21019000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
15044000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
112413000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29960000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30428000 USD
CY2014Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
0 USD
CY2015Q2 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
1087000 USD
CY2014Q4 us-gaap Derivative Assets
DerivativeAssets
2011000 USD
CY2015Q2 us-gaap Derivative Assets
DerivativeAssets
1087000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
2011000 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1087000 USD
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
2011000 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
0 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3050000 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
1963000 USD
CY2015Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3050000 USD
CY2015Q2 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
1087000 USD
CY2014Q2 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
7645000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
14549000 USD
CY2015Q2 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
1451000 USD
CY2014Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
CY2015Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.68
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.61
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.68
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-1306000 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
242000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
449000 USD
CY2015Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1153000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2037000 USD
CY2014Q4 us-gaap Foreign Currency Cash Flow Hedge Asset At Fair Value
ForeignCurrencyCashFlowHedgeAssetAtFairValue
2011000 USD
CY2014Q4 us-gaap Foreign Currency Cash Flow Hedge Liability At Fair Value
ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
0 USD
CY2014Q4 us-gaap Goodwill
Goodwill
39915000 USD
CY2015Q2 us-gaap Goodwill
Goodwill
50384000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-159089000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-391200000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-188848000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-387454000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-158396000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-389704000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-190861000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-389266000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-159089000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-391200000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-220992000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-419696000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.68
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.68
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.78
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.61
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.68
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.68
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.78
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.61
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-293000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-639000 USD
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-293000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-639000 USD
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
693000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1496000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30131000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30430000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
798000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1022000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7671000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3033000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2518000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21197000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-9459000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
38206000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5866000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9303000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1194000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9426000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
0 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
6346000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17538000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15397000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
21975000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
0 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-2277000 USD
CY2014Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15585000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-31302000 USD
CY2015Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21111000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42418000 USD
us-gaap Interest Paid
InterestPaid
31933000 USD
us-gaap Interest Paid
InterestPaid
12777000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1834000 USD
CY2015Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2977000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
30848000 USD
CY2015Q2 us-gaap Inventory Net
InventoryNet
42113000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8506000 USD
CY2015Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8147000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20508000 USD
CY2015Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30989000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
1238496000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
1325857000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2334679000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2374073000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
368254000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
373823000 USD
CY2014Q4 us-gaap Minority Interest
MinorityInterest
21177000 USD
CY2015Q2 us-gaap Minority Interest
MinorityInterest
153252000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-148741000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
245284000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
83821000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
56503000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
69475000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
492481000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-303682000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-302394000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-159382000 USD
us-gaap Net Income Loss
NetIncomeLoss
-391839000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-188848000 USD
us-gaap Net Income Loss
NetIncomeLoss
-387454000 USD
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32144000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32242000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
25564000 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
164317000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-180542000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-396584000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-171164000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-343149000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3265000 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9136000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
300000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-20000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
281000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
353000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1828000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1220000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
274000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
283000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2498000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2624000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-89000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-125000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-4280000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-3974000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
82000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
55000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-46000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
130000 USD
CY2014Q4 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
29000000 USD
CY2015Q2 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
284340000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4797000 USD
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13200000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21707000 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
41252000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-22000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6045000 USD
CY2014Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
36700000 USD
CY2014Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
36700000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37731000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38182000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1414000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3699000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
528000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-87000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11884000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
14441000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
703977000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
125655000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
80000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27227000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23978000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44175000 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53289000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
117947000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
87850000 USD
us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
0 USD
us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
13386000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
8050000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
801206000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
741725000 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-159382000 USD
us-gaap Profit Loss
ProfitLoss
-391839000 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-220992000 USD
us-gaap Profit Loss
ProfitLoss
-419696000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
715812000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
713378000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
17000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
2604000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
30292000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
30292000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
224487000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
463104000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
223858000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
439457000 USD
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
21900000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8418000 USD
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
88318000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
176000 USD
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
22146000 USD
CY2014Q2 us-gaap Restructuring Charges
RestructuringCharges
-270000 USD
us-gaap Restructuring Charges
RestructuringCharges
5918000 USD
CY2015Q2 us-gaap Restructuring Charges
RestructuringCharges
2128000 USD
us-gaap Restructuring Charges
RestructuringCharges
-1144000 USD
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
33107000 USD
CY2015Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
10166000 USD
CY2014Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
12748000 USD
CY2015Q2 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
9677000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-9369000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-26012000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4705450000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5092904000 USD
CY2014Q2 us-gaap Revenues
Revenues
138421000 USD
us-gaap Revenues
Revenues
256872000 USD
CY2015Q2 us-gaap Revenues
Revenues
166076000 USD
us-gaap Revenues
Revenues
304585000 USD
CY2014Q2 us-gaap Royalty Revenue
RoyaltyRevenue
13015000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
23748000 USD
CY2015Q2 us-gaap Royalty Revenue
RoyaltyRevenue
5077000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
11869000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77446000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
151658000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
94394000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
122319000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
225780000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
160388000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
291263000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
180254000 USD
CY2014Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
280569000 USD
CY2015Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
251939000 USD
CY2014Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
14206000 USD
CY2015Q2 us-gaap Senior Notes Current
SeniorNotesCurrent
42873000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
89024000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
120645000 USD
CY2015Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
5653000 shares
CY2015Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
11933000 shares
CY2015Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
52.06
CY2015Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
66.92
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y2M19D
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
117947000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
87354000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
1075006000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
894964000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1356405000 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1172269000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1096183000 USD
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1048216000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
900000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
900000 USD
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-7254000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
36023000 USD
CY2015Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
32433000 USD
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
233808000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
233353000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
240757000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
240129000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
233808000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
233353000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
240757000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
240129000 shares
CY2015Q2 vrtx Business Acquisition Contingent Consideration Commercial Milestones And Royalties Discount Rate
BusinessAcquisitionContingentConsiderationCommercialMilestonesAndRoyaltiesDiscountRate
0.066
CY2015Q2 vrtx Business Acquisition Contingent Consideration Development Milestones Discount Rate High End Of Range
BusinessAcquisitionContingentConsiderationDevelopmentMilestonesDiscountRateHighEndOfRange
0.059
CY2015Q2 vrtx Business Acquisition Contingent Consideration Development Milestones Discount Rate Low End Of Range
BusinessAcquisitionContingentConsiderationDevelopmentMilestonesDiscountRateLowEndOfRange
0.041
CY2014Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1387106000 USD
CY2015Q2 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1016450000 USD
CY2014Q4 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1387229000 USD
CY2015Q2 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1016443000 USD
CY2014Q4 vrtx Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain
88000 USD
CY2015Q2 vrtx Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain
41000 USD
CY2014Q4 vrtx Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross
211000 USD
CY2015Q2 vrtx Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross
34000 USD
CY2014Q2 vrtx Collaborative Revenues
CollaborativeRevenues
3087000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
7344000 USD
CY2015Q2 vrtx Collaborative Revenues
CollaborativeRevenues
611000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
1453000 USD
CY2014Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
473073000 USD
CY2015Q2 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
472834000 USD
CY2014Q4 vrtx Constructionfinancingleaseobligationcurrentandnoncurrent
Constructionfinancingleaseobligationcurrentandnoncurrent
473400000 USD
CY2015Q2 vrtx Constructionfinancingleaseobligationcurrentandnoncurrent
Constructionfinancingleaseobligationcurrentandnoncurrent
473200000 USD
CY2015Q2 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
35400000 USD
CY2014Q4 vrtx Derivative Asset Fair Value Gross Asset Collateral And Other Set Off Against Gross Assets Subject To Offsetting Enforceable Master Netting Arrangement Or Similar Agreement
DerivativeAssetFairValueGrossAssetCollateralAndOtherSetOffAgainstGrossAssetsSubjectToOffsettingEnforceableMasterNettingArrangementOrSimilarAgreement
0 USD
CY2015Q2 vrtx Derivative Asset Fair Value Gross Asset Collateral And Other Set Off Against Gross Assets Subject To Offsetting Enforceable Master Netting Arrangement Or Similar Agreement
DerivativeAssetFairValueGrossAssetCollateralAndOtherSetOffAgainstGrossAssetsSubjectToOffsettingEnforceableMasterNettingArrangementOrSimilarAgreement
0 USD
CY2015Q2 vrtx Derivative Liability Fair Value Gross Liability Collateral And Other Set Off Against Gross Assets Subject To Offsetting Enforceable Master Netting Arrangement Or Similar Agreement
DerivativeLiabilityFairValueGrossLiabilityCollateralAndOtherSetOffAgainstGrossAssetsSubjectToOffsettingEnforceableMasterNettingArrangementOrSimilarAgreement
0 USD
CY2011 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 lease
CY2011 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 building
CY2011 vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
P10Y
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2015Q2 vrtx Unrecognized Tax Benefits Reduction Resultingfrom Lapseof Applicable Statuteof Limitationsand Settlementswith Taxing Authorities Estimatedin Next Fiscal Year
UnrecognizedTaxBenefitsReductionResultingfromLapseofApplicableStatuteofLimitationsandSettlementswithTaxingAuthoritiesEstimatedinNextFiscalYear
500000 USD
vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
24602000 USD
vrtx Valuation Allowances And Reserves Sales Credits Or Payments Current
ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent
20938000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, goodwill, noncontrolling interest, the consolidation of VIEs, leases and the provision for or benefit from income taxes. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> Annual Report on Form&#160;10-K.</font></div></div>

Files In Submission

Name View Source Status
0000875320-15-000047-index-headers.html Edgar Link pending
0000875320-15-000047-index.html Edgar Link pending
0000875320-15-000047.txt Edgar Link pending
0000875320-15-000047-xbrl.zip Edgar Link pending
a2015q210-q.htm Edgar Link pending
a2015q210-q_exhibit102.htm Edgar Link pending
a2015q210-q_exhibit31.htm Edgar Link pending
a2015q210-q_exhibit311.htm Edgar Link pending
a2015q210-q_exhibit312.htm Edgar Link pending
a2015q210-q_exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
parionagreementimage1.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20150630.xml Edgar Link completed
vrtx-20150630.xsd Edgar Link pending
vrtx-20150630_cal.xml Edgar Link unprocessable
vrtx-20150630_def.xml Edgar Link unprocessable
vrtx-20150630_lab.xml Edgar Link unprocessable
vrtx-20150630_pre.xml Edgar Link unprocessable